Skip to content
BridGene Biosciences
Menu
  • About
  • Technology
  • Team
  • Careers
  • News
  • Contact

Month: March 2021

All News / Collaboration

BridGene Biosciences Announces Research Collaboration with Takeda to Discover Small Molecule Drugs for “Undruggable” Targets

BridGene Eligible to Receive More Than $500 Million in Potential Upfront and Milestone Payments Sunnyvale, CA, March 30, 2021 – BridGene Biosciences, Inc., a biotechnology company using cutting-edge technology to discover and develop small molecules for hard-to-drug therapeutic targets, announced today …

Recent Posts

  • BridGene Biosciences Announces Research Collaboration with Takeda to Discover Small Molecule Drugs for “Undruggable” Targets
  • Nobel laureate Professor Arieh Warshel Joined the SAB of BridGene
  • BridGene Biosciences 1st SAB Meeting

Archives

  • March 2021
  • December 2018
  • May 2018

Categories

  • All News
  • Collaboration
  • SAB
Copyright © 2021 BridGene Biosciences – OnePress theme by FameThemes